Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
LATEST IN drug discovery
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
Ask an expert: Associate Professor Temidayo Akenroye explore issues of sustainability in supply chains in three new books
Akenroye edited “Indigenous Supply Chain Management in Africa” and “Green Innovations in Supply Chain Management,” both published last fall. His latest book, “Digitizing Healthcare Supply Chains in Africa,” is due out this spring.
MORE IN drug discovery
LATEST NEWS
- Ask an expert: Associate Professor Temidayo Akenroye explore issues of sustainability in supply chains in three new books
- Eye on UMSL: Global engagement
- UMSL partnering with FOCUS St. Louis to host second annual Start With Leadership Conference
- Kristin Sobolik to step down as UMSL chancellor effective July 1
- UMSL students and alumni join game development professionals and first-time creators for Global Game Jam
- UMSL Tritons weekly rewind
- Associate Teaching Professor Jill Bernard Bracy discusses supply chain education in latest episode of Inside UMSL podcast
- Nearly 1,000 band, choir, orchestra and visual art students attend annual Des Lee Fine Arts Festival at UMSL
- UMSL alum Martin Goebel to exhibit work at the Smithsonian Craft Show
- Elaina Rohlfing finds calling in computer science at UMSL, begins pursuit of PhD
